Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 53 entries
Sorted by: Best Match Show Resources per page
Infectious Process Complicating Renal Transplantation.

Postgraduate medicine

Sparagana M, Rubnitz ME, Jonasson O, Vana M.
PMID: 27409394
Postgrad Med. 1974 Dec;56(7):109-115. doi: 10.1080/00325481.1974.11713931.

No abstract available.

Cite
Sparagana M, Rubnitz ME, Jonasson O, et al. Infectious Process Complicating Renal Transplantation. Postgrad Med. 1974;56(7):109-115doi: 10.1080/00325481.1974.11713931.
Sparagana, M., Rubnitz, M. E., Jonasson, O., & Vana, M. (1974). Infectious Process Complicating Renal Transplantation. Postgraduate medicine, 56(7), 109-115. https://doi.org/10.1080/00325481.1974.11713931
Sparagana, Mario, et al. "Infectious Process Complicating Renal Transplantation." Postgraduate medicine vol. 56,7 (1974): 109-115. doi: https://doi.org/10.1080/00325481.1974.11713931
Sparagana M, Rubnitz ME, Jonasson O, Vana M. Infectious Process Complicating Renal Transplantation. Postgrad Med. 1974 Dec;56(7):109-115. doi: 10.1080/00325481.1974.11713931. PMID: 27409394.
Copy Download .nbib Format: NLM
Methods for Acquisition of Quantitative Data from Confocal Images of Gene Expression in situ.

Cell and tissue biology

Surkova SY, Myasnikova EM, Kozlov KN, Samsonova AA, Reinitz J, Samsonova MG.
PMID: 19343098
Cell tissue biol. 2008 Apr;2(2):200-215. doi: 10.1134/S1990519X08020156.

In this review, we summarize original methods for the extraction of quantitative information from confocal images of gene-expression patterns. These methods include image segmentation, the extraction of quantitative numerical data on gene expression, and the removal of background signal...

Cite
Surkova SY, Myasnikova EM, Kozlov KN, et al. Methods for Acquisition of Quantitative Data from Confocal Images of Gene Expression in situ. Cell tissue biol. 2008;2(2):200-215doi: 10.1134/S1990519X08020156.
Surkova, S. Y., Myasnikova, E. M., Kozlov, K. N., Samsonova, A. A., Reinitz, J., & Samsonova, M. G. (2008). Methods for Acquisition of Quantitative Data from Confocal Images of Gene Expression in situ. Cell and tissue biology, 2(2), 200-215. https://doi.org/10.1134/S1990519X08020156
Surkova, S Yu, et al. "Methods for Acquisition of Quantitative Data from Confocal Images of Gene Expression in situ." Cell and tissue biology vol. 2,2 (2008): 200-215. doi: https://doi.org/10.1134/S1990519X08020156
Surkova SY, Myasnikova EM, Kozlov KN, Samsonova AA, Reinitz J, Samsonova MG. Methods for Acquisition of Quantitative Data from Confocal Images of Gene Expression in situ. Cell tissue biol. 2008 Apr;2(2):200-215. doi: 10.1134/S1990519X08020156. PMID: 19343098; PMCID: PMC2630218.
Copy Download .nbib Format: NLM
An Unusual Diaphragmatic Hernia Found in the Course of Dissection of a White Male, Aged Sixty.

The Yale journal of biology and medicine

Budnitz J, Miller M, Ferris HB.
PMID: 21433627
Yale J Biol Med. 1934 Dec;7(2):129-32.

No abstract available.

Cite
Budnitz J, Miller M, Ferris HB. An Unusual Diaphragmatic Hernia Found in the Course of Dissection of a White Male, Aged Sixty. Yale J Biol Med. 1934;7(2):129-32
Budnitz, J., Miller, M., & Ferris, H. B. (1934). An Unusual Diaphragmatic Hernia Found in the Course of Dissection of a White Male, Aged Sixty. The Yale journal of biology and medicine, 7(2), 129-32.
Budnitz, J, et al. "An Unusual Diaphragmatic Hernia Found in the Course of Dissection of a White Male, Aged Sixty." The Yale journal of biology and medicine vol. 7,2 (1934): 129-32.
Budnitz J, Miller M, Ferris HB. An Unusual Diaphragmatic Hernia Found in the Course of Dissection of a White Male, Aged Sixty. Yale J Biol Med. 1934 Dec;7(2):129-32. PMID: 21433627; PMCID: PMC2601140.
Copy Download .nbib Format: NLM
Comprehensive analysis of dose intensity of acute lymphoblastic leukemia chemotherapy.

Haematologica

Karol SE, Pei D, Smith CA, Liu Y, Yang W, Kornegay NM, Panetta JC, Crews KR, Cheng C, Finch ER, Inaba H, Metzger ML, Rubnitz JE, Ribeiro RC, Gruber TA, Yang JJ, Evans WE, Jeha S, Pui CH, Relling MV.
PMID: 34196166
Haematologica. 2021 Jul 01; doi: 10.3324/haematol.2021.278411. Epub 2021 Jul 01.

Chemotherapy dosages are often compromised, but most reports lack data on dosages that are actually delivered. In two consecutive acute lymphoblastic leukemia (ALL) trials that differed in their asparaginase formulation, native E. coli L-asparaginase in St. Jude Total 15...

Cite
Karol SE, Pei D, Smith CA, et al. Comprehensive analysis of dose intensity of acute lymphoblastic leukemia chemotherapy. Haematologica. 2021;doi: 10.3324/haematol.2021.278411.
Karol, S. E., Pei, D., Smith, C. A., Liu, Y., Yang, W., Kornegay, N. M., Panetta, J. C., Crews, K. R., Cheng, C., Finch, E. R., Inaba, H., Metzger, M. L., Rubnitz, J. E., Ribeiro, R. C., Gruber, T. A., Yang, J. J., Evans, W. E., Jeha, S., Pui, C. H., & Relling, M. V. (2021). Comprehensive analysis of dose intensity of acute lymphoblastic leukemia chemotherapy. Haematologica, . https://doi.org/10.3324/haematol.2021.278411
Karol, Seth E, et al. "Comprehensive analysis of dose intensity of acute lymphoblastic leukemia chemotherapy." Haematologica vol. (2021). doi: https://doi.org/10.3324/haematol.2021.278411
Karol SE, Pei D, Smith CA, Liu Y, Yang W, Kornegay NM, Panetta JC, Crews KR, Cheng C, Finch ER, Inaba H, Metzger ML, Rubnitz JE, Ribeiro RC, Gruber TA, Yang JJ, Evans WE, Jeha S, Pui CH, Relling MV. Comprehensive analysis of dose intensity of acute lymphoblastic leukemia chemotherapy. Haematologica. 2021 Jul 01; doi: 10.3324/haematol.2021.278411. Epub 2021 Jul 01. PMID: 34196166.
Copy Download .nbib Format: NLM
Clinical significance of novel subtypes of acute lymphoblastic leukemia in the context of minimal residual disease-directed therapy.

Blood cancer discovery

Jeha S, Choi J, Roberts KG, Pei D, Coustan-Smith E, Inaba H, Rubnitz JE, Ribeiro RC, Gruber TA, Raimondi SC, Karol SE, Qu C, Brady SW, Gu Z, Yang JJ, Cheng C, Downing JR, Evans WE, Relling MV, Campana D, Mullighan CG, Pui CH.
PMID: 34250504
Blood Cancer Discov. 2021 Jul;2(4):326-337. doi: 10.1158/2643-3230.bcd-20-0229.

We evaluate clinical significance of recently identified subtypes of acute lymphoblastic leukemia (ALL) in 598 children treated with minimal residual disease (MRD)-directed therapy. Among the 16 B-ALL and 8 T-ALL subtypes identified by next generation sequencing,

Cite
Jeha S, Choi J, Roberts KG, et al. Clinical significance of novel subtypes of acute lymphoblastic leukemia in the context of minimal residual disease-directed therapy. Blood Cancer Discov. 2021;2(4):326-337doi: 10.1158/2643-3230.bcd-20-0229.
Jeha, S., Choi, J., Roberts, K. G., Pei, D., Coustan-Smith, E., Inaba, H., Rubnitz, J. E., Ribeiro, R. C., Gruber, T. A., Raimondi, S. C., Karol, S. E., Qu, C., Brady, S. W., Gu, Z., Yang, J. J., Cheng, C., Downing, J. R., Evans, W. E., Relling, M. V., Campana, D., Mullighan, C. G., & Pui, C. H. (2021). Clinical significance of novel subtypes of acute lymphoblastic leukemia in the context of minimal residual disease-directed therapy. Blood cancer discovery, 2(4), 326-337. https://doi.org/10.1158/2643-3230.bcd-20-0229
Jeha, Sima, et al. "Clinical significance of novel subtypes of acute lymphoblastic leukemia in the context of minimal residual disease-directed therapy." Blood cancer discovery vol. 2,4 (2021): 326-337. doi: https://doi.org/10.1158/2643-3230.bcd-20-0229
Jeha S, Choi J, Roberts KG, Pei D, Coustan-Smith E, Inaba H, Rubnitz JE, Ribeiro RC, Gruber TA, Raimondi SC, Karol SE, Qu C, Brady SW, Gu Z, Yang JJ, Cheng C, Downing JR, Evans WE, Relling MV, Campana D, Mullighan CG, Pui CH. Clinical significance of novel subtypes of acute lymphoblastic leukemia in the context of minimal residual disease-directed therapy. Blood Cancer Discov. 2021 Jul;2(4):326-337. doi: 10.1158/2643-3230.bcd-20-0229. PMID: 34250504; PMCID: PMC8265990.
Copy Download .nbib Format: NLM
The Algorithm Examining the Risk of Massive Transfusion (ALERT) Score Accurately Predicts Massive Transfusion at the Scene of Injury and on Arrival to the Trauma Bay: A Retrospective Analysis.

Shock (Augusta, Ga.)

Chow JH, Richards JE, Galvagno SM, Coleman PJ, Lankford AS, Hendrix C, Dunitz J, Ibrahim I, Ghneim M, Tanaka KA, Scalea TM, Mazzeffi MA, Hu P.
PMID: 34524267
Shock. 2021 Oct 01;56(4):529-536. doi: 10.1097/SHK.0000000000001772.

BACKGROUND: Massive transfusion (MT) is required to resuscitate traumatically injured patients with complex derangements. Scoring systems for MT typically require laboratory values and radiological imaging that may delay the prediction of MT.STUDY DESIGN: The Trauma ALgorithm Examining the Risk...

Cite
Chow JH, Richards JE, Galvagno SM, et al. The Algorithm Examining the Risk of Massive Transfusion (ALERT) Score Accurately Predicts Massive Transfusion at the Scene of Injury and on Arrival to the Trauma Bay: A Retrospective Analysis. Shock. 2021;56(4):529-536doi: 10.1097/SHK.0000000000001772.
Chow, J. H., Richards, J. E., Galvagno, S. M., Coleman, P. J., Lankford, A. S., Hendrix, C., Dunitz, J., Ibrahim, I., Ghneim, M., Tanaka, K. A., Scalea, T. M., Mazzeffi, M. A., & Hu, P. (2021). The Algorithm Examining the Risk of Massive Transfusion (ALERT) Score Accurately Predicts Massive Transfusion at the Scene of Injury and on Arrival to the Trauma Bay: A Retrospective Analysis. Shock (Augusta, Ga.), 56(4), 529-536. https://doi.org/10.1097/SHK.0000000000001772
Chow, Jonathan H, et al. "The Algorithm Examining the Risk of Massive Transfusion (ALERT) Score Accurately Predicts Massive Transfusion at the Scene of Injury and on Arrival to the Trauma Bay: A Retrospective Analysis." Shock (Augusta, Ga.) vol. 56,4 (2021): 529-536. doi: https://doi.org/10.1097/SHK.0000000000001772
Chow JH, Richards JE, Galvagno SM, Coleman PJ, Lankford AS, Hendrix C, Dunitz J, Ibrahim I, Ghneim M, Tanaka KA, Scalea TM, Mazzeffi MA, Hu P. The Algorithm Examining the Risk of Massive Transfusion (ALERT) Score Accurately Predicts Massive Transfusion at the Scene of Injury and on Arrival to the Trauma Bay: A Retrospective Analysis. Shock. 2021 Oct 01;56(4):529-536. doi: 10.1097/SHK.0000000000001772. PMID: 34524267.
Copy Download .nbib Format: NLM
[No title available]

Journal of clinical medicine

Rehnitz J, Capp E, Messmer B, Nguyen XP, Germeyer A, Freis A, Dietrich JE, Hinderhofer K, Strowitzki T, Vogt PH.
PMID: 34501340
J Clin Med. 2021 Aug 30;10(17). doi: 10.3390/jcm10173892.

We aimed to determine whether a functional link with impact on female ovarian reserve exists between

Cite
Rehnitz J, Capp E, Messmer B, et al. . J Clin Med. 2021;10(17)doi: 10.3390/jcm10173892.
Rehnitz, J., Capp, E., Messmer, B., Nguyen, X. P., Germeyer, A., Freis, A., Dietrich, J. E., Hinderhofer, K., Strowitzki, T., & Vogt, P. H. (2021). . Journal of clinical medicine, 10(17), . https://doi.org/10.3390/jcm10173892
Rehnitz, Julia, et al. "." Journal of clinical medicine vol. 10,17 (2021). doi: https://doi.org/10.3390/jcm10173892
Rehnitz J, Capp E, Messmer B, Nguyen XP, Germeyer A, Freis A, Dietrich JE, Hinderhofer K, Strowitzki T, Vogt PH. . J Clin Med. 2021 Aug 30;10(17). doi: 10.3390/jcm10173892. PMID: 34501340; PMCID: PMC8432207.
Copy Download .nbib Format: NLM
Employing nanobodies for immune landscape profiling by PET imaging in mice.

STAR protocols

Teunissen AJP, Abousaway OB, Munitz J, van Leent MMT, Toner YC, Priem B, Senders ML, Pérez-Medina C, Mulder WJM, Rashidian M.
PMID: 33899016
STAR Protoc. 2021 Apr 05;2(2):100434. doi: 10.1016/j.xpro.2021.100434. eCollection 2021 Jun 18.

Noninvasive immunoimaging holds great potential for studying and stratifying disease as well as therapeutic efficacy. Radiolabeled single-domain antibody fragments (i.e., nanobodies) are appealing probes for immune landscape profiling, as they display high stability, rapid targeting, and excellent specificity, while...

Cite
Teunissen AJP, Abousaway OB, Munitz J, et al. Employing nanobodies for immune landscape profiling by PET imaging in mice. STAR Protoc. 2021;2(2):100434doi: 10.1016/j.xpro.2021.100434.
Teunissen, A. J. P., Abousaway, O. B., Munitz, J., van Leent, M. M. T., Toner, Y. C., Priem, B., Senders, M. L., Pérez-Medina, C., Mulder, W. J. M., & Rashidian, M. (2021). Employing nanobodies for immune landscape profiling by PET imaging in mice. STAR protocols, 2(2), 100434. https://doi.org/10.1016/j.xpro.2021.100434
Teunissen, Abraham J P, et al. "Employing nanobodies for immune landscape profiling by PET imaging in mice." STAR protocols vol. 2,2 (2021): 100434. doi: https://doi.org/10.1016/j.xpro.2021.100434
Teunissen AJP, Abousaway OB, Munitz J, van Leent MMT, Toner YC, Priem B, Senders ML, Pérez-Medina C, Mulder WJM, Rashidian M. Employing nanobodies for immune landscape profiling by PET imaging in mice. STAR Protoc. 2021 Apr 05;2(2):100434. doi: 10.1016/j.xpro.2021.100434. eCollection 2021 Jun 18. PMID: 33899016; PMCID: PMC8056265.
Copy Download .nbib Format: NLM
Chromosome 2q gain and epigenetic silencing of GATA3 in microglandular adenosis of the breast.

The journal of pathology. Clinical research

Radner M, van Luttikhuizen JL, Bartels S, Bublitz J, Grote I, Rieger L, Christgen H, Stark H, Werlein C, Lafos M, Steinemann D, Lehmann U, Christgen M, Kreipe H.
PMID: 33382535
J Pathol Clin Res. 2021 May;7(3):220-232. doi: 10.1002/cjp2.195. Epub 2020 Dec 31.

Microglandular adenosis (MGA) represents a rare neoplasm of the mammary gland, which in a subset of cases may be associated with triple-negative breast cancer (BC). The biology of MGA is poorly understood. In this study, eight MGA cases (n...

Cite
Radner M, van Luttikhuizen JL, Bartels S, et al. Chromosome 2q gain and epigenetic silencing of GATA3 in microglandular adenosis of the breast. J Pathol Clin Res. 2020;7(3):220-232doi: 10.1002/cjp2.195.
Radner, M., van Luttikhuizen, J. L., Bartels, S., Bublitz, J., Grote, I., Rieger, L., Christgen, H., Stark, H., Werlein, C., Lafos, M., Steinemann, D., Lehmann, U., Christgen, M., & Kreipe, H. (2021). Chromosome 2q gain and epigenetic silencing of GATA3 in microglandular adenosis of the breast. The journal of pathology. Clinical research, 7(3), 220-232. https://doi.org/10.1002/cjp2.195
Radner, Martin, et al. "Chromosome 2q gain and epigenetic silencing of GATA3 in microglandular adenosis of the breast." The journal of pathology. Clinical research vol. 7,3 (2021): 220-232. doi: https://doi.org/10.1002/cjp2.195
Radner M, van Luttikhuizen JL, Bartels S, Bublitz J, Grote I, Rieger L, Christgen H, Stark H, Werlein C, Lafos M, Steinemann D, Lehmann U, Christgen M, Kreipe H. Chromosome 2q gain and epigenetic silencing of GATA3 in microglandular adenosis of the breast. J Pathol Clin Res. 2021 May;7(3):220-232. doi: 10.1002/cjp2.195. Epub 2020 Dec 31. PMID: 33382535; PMCID: PMC8073017.
Copy Download .nbib Format: NLM
Medical Outcomes, Quality of Life, and Family Perceptions for Outpatient vs Inpatient Neutropenia Management After Chemotherapy for Pediatric Acute Myeloid Leukemia.

JAMA network open

Getz KD, Szymczak JE, Li Y, Madding R, Huang YV, Aftandilian C, Arnold SD, Bona KO, Caywood E, Collier AB, Gramatges MM, Henry M, Lotterman C, Maloney K, Mian A, Mody R, Morgan E, Raetz EA, Rubnitz J, Verma A, Winick N, Wilkes JJ, Yu JC, Fisher BT, Aplenc R.
PMID: 34709389
JAMA Netw Open. 2021 Oct 01;4(10):e2128385. doi: 10.1001/jamanetworkopen.2021.28385.

IMPORTANCE: Pediatric acute myeloid leukemia (AML) requires multiple courses of intensive chemotherapy that result in neutropenia, with significant risk for infectious complications. Supportive care guidelines recommend hospitalization until neutrophil recovery. However, there are little data to support inpatient over...

Cite
Getz KD, Szymczak JE, Li Y, et al. Medical Outcomes, Quality of Life, and Family Perceptions for Outpatient vs Inpatient Neutropenia Management After Chemotherapy for Pediatric Acute Myeloid Leukemia. JAMA Netw Open. 2021;4(10):e2128385doi: 10.1001/jamanetworkopen.2021.28385.
Getz, K. D., Szymczak, J. E., Li, Y., Madding, R., Huang, Y. V., Aftandilian, C., Arnold, S. D., Bona, K. O., Caywood, E., Collier, A. B., Gramatges, M. M., Henry, M., Lotterman, C., Maloney, K., Mian, A., Mody, R., Morgan, E., Raetz, E. A., Rubnitz, J., Verma, A., Winick, N., Wilkes, J. J., Yu, J. C., Fisher, B. T., & Aplenc, R. (2021). Medical Outcomes, Quality of Life, and Family Perceptions for Outpatient vs Inpatient Neutropenia Management After Chemotherapy for Pediatric Acute Myeloid Leukemia. JAMA network open, 4(10), e2128385. https://doi.org/10.1001/jamanetworkopen.2021.28385
Getz, Kelly D, et al. "Medical Outcomes, Quality of Life, and Family Perceptions for Outpatient vs Inpatient Neutropenia Management After Chemotherapy for Pediatric Acute Myeloid Leukemia." JAMA network open vol. 4,10 (2021): e2128385. doi: https://doi.org/10.1001/jamanetworkopen.2021.28385
Getz KD, Szymczak JE, Li Y, Madding R, Huang YV, Aftandilian C, Arnold SD, Bona KO, Caywood E, Collier AB, Gramatges MM, Henry M, Lotterman C, Maloney K, Mian A, Mody R, Morgan E, Raetz EA, Rubnitz J, Verma A, Winick N, Wilkes JJ, Yu JC, Fisher BT, Aplenc R. Medical Outcomes, Quality of Life, and Family Perceptions for Outpatient vs Inpatient Neutropenia Management After Chemotherapy for Pediatric Acute Myeloid Leukemia. JAMA Netw Open. 2021 Oct 01;4(10):e2128385. doi: 10.1001/jamanetworkopen.2021.28385. PMID: 34709389; PMCID: PMC8554641.
Copy Download .nbib Format: NLM
Role of Geographic Risk Factors in COVID-19 Epidemiology: Longitudinal Geospatial Analysis.

Mayo Clinic proceedings. Innovations, quality & outcomes

Juhn YJ, Wheeler P, Wi CI, Bublitz J, Ryu E, Ristagno EH, Patten C.
PMID: 34308261
Mayo Clin Proc Innov Qual Outcomes. 2021 Oct;5(5):916-927. doi: 10.1016/j.mayocpiqo.2021.06.011. Epub 2021 Jul 12.

OBJECTIVE: To perform a geospatial and temporal trend analysis for coronavirus disease 2019 (COVID-19) in a Midwest community to identify and characterize hot spots for COVID-19.PARTICIPANTS AND METHODS: We conducted a population-based longitudinal surveillance assessing the semimonthly geospatial trends...

Cite
Juhn YJ, Wheeler P, Wi CI, et al. Role of Geographic Risk Factors in COVID-19 Epidemiology: Longitudinal Geospatial Analysis. Mayo Clin Proc Innov Qual Outcomes. 2021;5(5):916-927doi: 10.1016/j.mayocpiqo.2021.06.011.
Juhn, Y. J., Wheeler, P., Wi, C. I., Bublitz, J., Ryu, E., Ristagno, E. H., & Patten, C. (2021). Role of Geographic Risk Factors in COVID-19 Epidemiology: Longitudinal Geospatial Analysis. Mayo Clinic proceedings. Innovations, quality & outcomes, 5(5), 916-927. https://doi.org/10.1016/j.mayocpiqo.2021.06.011
Juhn, Young J, et al. "Role of Geographic Risk Factors in COVID-19 Epidemiology: Longitudinal Geospatial Analysis." Mayo Clinic proceedings. Innovations, quality & outcomes vol. 5,5 (2021): 916-927. doi: https://doi.org/10.1016/j.mayocpiqo.2021.06.011
Juhn YJ, Wheeler P, Wi CI, Bublitz J, Ryu E, Ristagno EH, Patten C. Role of Geographic Risk Factors in COVID-19 Epidemiology: Longitudinal Geospatial Analysis. Mayo Clin Proc Innov Qual Outcomes. 2021 Oct;5(5):916-927. doi: 10.1016/j.mayocpiqo.2021.06.011. Epub 2021 Jul 12. PMID: 34308261; PMCID: PMC8272975.
Copy Download .nbib Format: NLM
Activity of venetoclax against relapsed acute undifferentiated leukemia.

Cancer

Caldwell KJ, Budhraja A, Opferman JT, Pui CH, Klco JM, Rubnitz JE.
PMID: 33823069
Cancer. 2021 Aug 01;127(15):2608-2611. doi: 10.1002/cncr.33531. Epub 2021 Apr 06.

No abstract available.

Cite
Caldwell KJ, Budhraja A, Opferman JT, et al. Activity of venetoclax against relapsed acute undifferentiated leukemia. Cancer. 2021;127(15):2608-2611doi: 10.1002/cncr.33531.
Caldwell, K. J., Budhraja, A., Opferman, J. T., Pui, C. H., Klco, J. M., & Rubnitz, J. E. (2021). Activity of venetoclax against relapsed acute undifferentiated leukemia. Cancer, 127(15), 2608-2611. https://doi.org/10.1002/cncr.33531
Caldwell, Kenneth J, et al. "Activity of venetoclax against relapsed acute undifferentiated leukemia." Cancer vol. 127,15 (2021): 2608-2611. doi: https://doi.org/10.1002/cncr.33531
Caldwell KJ, Budhraja A, Opferman JT, Pui CH, Klco JM, Rubnitz JE. Activity of venetoclax against relapsed acute undifferentiated leukemia. Cancer. 2021 Aug 01;127(15):2608-2611. doi: 10.1002/cncr.33531. Epub 2021 Apr 06. PMID: 33823069.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 53 entries